Skip to main content
Equibles

ALIVUS · Alivus Life Sciences Limited · Financials

Use ALIVUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALIVUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,460.60 INR +16.90 (+1.17%) At close · Nov 13
Rebalance outlook locked
Market Cap
179.32B INR
Shares
122.77M
Volume · Nov 13 600.13K Avg daily vol (3M) 242.47K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
25.52B +6.9%
FY2026 Revenue FY2022–FY2026
Net Income
5.64B +16.2%
FY2026 Net Income FY2022–FY2026
Operating Cash Flow
5.65B +44.4%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022
INR 26.84B 25.52B 23.87B 22.83B 21.61B 21.23B
INR 822.67M 753.57M 606.09M 534.52M 420.94M 378.77M
INR 54.16M 53.72M 24.14M 15.46M 5.47M 279.62M
INR 8.88B 7.51B 6.54B 6.31B 6.29B 5.65B
INR 2.19B 1.87B 1.69B 1.6B 1.62B 1.46B
INR 6.7B 5.64B 4.86B 4.71B 4.67B 4.19B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 8.52B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.